Has Clifford Kavinsky, MD received payments from drug or device companies?

Yes. Drug and device makers reported $260,225 in general payments to Clifford Kavinsky, MD across 627 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Clifford Kavinsky, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Clifford Kavinsky, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Clifford Kavinsky, MD

Cardiovascular Disease · Maywood, ILNPI 1336165612

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $175,020 of the $260,225 with a category attached, or 67.3%. 15 manufacturers reported payments, led by Edwards Lifesciences at 33.9% of the total. Reporting peaked in 2023 at $77,294 and has fallen 97.9% since, to $1,652 in 2025. Among cardiovascular disease clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$260,225in general payments, 2019–2025

Across 627 payments — averaging $415.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$88K
Medical Device Business Services, Inc.$72K
Medtronic$44K
Abbott$38K
W. L. Gore & Associates, Inc.$14K
Biosense Webster, Inc.$3K
plus $1K from 9 others

$1,172,312in research payments, 2019–2025

Across 294 payments — averaging $3987.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$721K
Abbott$279K
W. L. Gore & Associates, Inc.$136K
Medtronic$36K

What the payments were for

Consulting fees$175,02067%
Speaking & faculty fees$31,51212%
Travel & lodging$30,47412%
Food & beverage$23,0019%
Entertainment$2180%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	144	$88,211
Medical Device Business Services, Inc.	101	$72,013
Medtronic(2 entities)	73	$43,744
Abbott	245	$37,689
W. L. Gore & Associates, Inc.	12	$14,058
Biosense Webster, Inc.	11	$3,049
Boston Scientific	27	$362
Teleflex LLC	2	$239
Opsens Inc.	3	$218
Cardiovascular Systems Inc.	2	$216
Cardiva Medical, Inc.	3	$158
Cardiac Dimensions, Inc.	1	$130
Philips North America LLC	1	$104
Baylis Medical Company Inc	1	$18
Pfizer	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$80,451
Carto 3$43,588
Carto 3 System$29,557
MitraClip$23,459
GORE CARDIOFORM Septal Occluder$13,985
CoreValve Evolut$10,447
MitraClip System$6,815
Mitra Clip system$2,533
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,632
SAPIEN 3 Ultra RESILIA$1,035
COREVALVE EVOLUT R$879
AMPLATZER Occluders$632
THE EDWARDS SAPIEN 3 VALVE WITH ALTERRA ADAPTIVE PRESTENT SYSTEM$334
TRICLIP$320
HARMONY$306
PORTICO$304
MANTA$239
NA$234
Coronary Orbital Atherectomy System$216
3F$182

How this compares

$260,225 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.

See all cardiovascular disease providers in Illinois →

Medicare billing

Part B allowed, 2024

$86,485

Medicare patients

309

Services billed

552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	17	$256

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Maywood

Niraj VarmaMaywood$522K
Mark RabbatMaywood$363K
Smit VasaiwalaMaywood$264K
Gregory MacalusoMaywood$165K
Dana JohnsonMaywood$104K
Erin CoglianeseMaywood$36K
Sandeep NathanChicago$892K
Alan BrownNaperville$858K
Azmey MatariehElgin$762K
Jay AlexanderBannockburn$744K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →